Live Breaking News & Updates on Yasir elamin

Critical condition: Violence against health care in conflict | 2023 - World

Analysis in English on occupied Palestinian territory and 19 other countries about Gender, Health and more; published on 22 May 2024 by Insecurity Insight and Safeguarding Health in Conflict

Haiti , Burkina-faso , Afghanistan , Congo , Israel , Khartoum , Al-khartum , Sudan , Tigray , Ethiopia , Central-african-republic , Russia

Critical condition: Violence against health care in conflict | 2023 - occupied Palestinian territory

Analysis in English on occupied Palestinian territory and 19 other countries about Gender, Health and more; published on 22 May 2024 by Insecurity Insight and Safeguarding Health in Conflict

Haiti , Ethiopia , Sudan , Burkina-faso , Tigray , Gaza , Israel-general , Israel , Syria , Afghanistan , Congo , Russia

Joint News Alert: Conflict in Sudan Pushes Health System to its Breaking Point - Sudan

Joint News Alert: Conflict in Sudan Pushes Health System to its Breaking Point - Sudan
reliefweb.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reliefweb.int Daily Mail and Mail on Sunday newspapers.

Port-sudan , Al-bar-ala-mar , Sudan , Qatar , Darfur , Gharb-darfur , Sudanese , Rabih-torbay , Yasir-elamin , Qatar-airways-cargo , Astral-aviation , Sudanese-american-physicians-association

Collaborative Effort Delivers $13 Million in Critical Medical Aid to Sudan Amid Ongoing Violence - Sudan

Collaborative Effort Delivers $13 Million in Critical Medical Aid to Sudan Amid Ongoing Violence - Sudan
reliefweb.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reliefweb.int Daily Mail and Mail on Sunday newspapers.

Haiti , Dubai , Dubayy , United-arab-emirates , Hong-kong , Port-sudan , Al-bar-ala-mar , Sudan , Washington , United-states , Nairobi , Nairobi-area

BRIGHTSTAR: Local Consolidative Therapy with Brigatinib in Tyrosine Kinase Inhibitor-Naïve ALK-Rearranged Metastatic NSCLC

Expert oncologist Yasir Elamin, MD, shares data from the BRIGHTSTAR trial and considers how it may inform real-world use of brigatinib in patient with ALK-rearranged metastatic non–small cell lung cancer.

Yasir-elamin , Local-consolidative-therapy , Tyrosine-kinase-inhibitor-na , Rearranged-metastatic , Nsclc , Non-small-cell-lung-cancer , Lung-cancer , Metastatic-nsclc , Metastatic-lung-cancer , Brightstar-trial , Brightstar-study